Harlan E. Shannon

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice

Jesús Gomeza, Harlan E. Shannon, Evi Kostenis et al. · Proceedings of the National Academy of Sciences · 1999 · 350 citations

Medicine, Neuroscience, Pharmacology +16

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M ₄ muscarinic acetylcholine receptor knockout mice

Jesús Gomeza, Lu Zhang, Evi Kostenis et al. · Proceedings of the National Academy of Sciences · 1999 · 321 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel et al. · Drug Metabolism and Disposition · 2015 · 281 citations

Medicine, Oncology, Pharmacology +17

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

Scott D. Gleason, Harlan E. Shannon · Psychopharmacology · 1997 · 217 citations

Medicine, Pharmacology, Psychiatry +13

Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction

Khuchtumur Bum‐Erdene, Donghui Zhou, Giovanni González-Gutiérrez et al. · Cell chemical biology · 2018 · 208 citations

Life Sciences, Biochemistry, Molecular Biology +17